|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0045093,
umls-concept:C0069717,
umls-concept:C0205195,
umls-concept:C0205208,
umls-concept:C0205269,
umls-concept:C0239307,
umls-concept:C0282460,
umls-concept:C1136080,
umls-concept:C1456649,
umls-concept:C1513822,
umls-concept:C1880171,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-3
|
|
pubmed:abstractText |
To assess objective response rates after 4 cycles of gemcitabine in combination with oxaliplatin in children and adolescents with relapsed or refractory solid tumours.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1879-0852
|
|
pubmed:author |
pubmed-author:AertsIsabelleI,
pubmed-author:BoosJoachimJ,
pubmed-author:ChisholmJuliaJ,
pubmed-author:ColosimoCesareC,
pubmed-author:CouanetDominiqueD,
pubmed-author:DevosAnnickA,
pubmed-author:DiasNathalieN,
pubmed-author:European Consortium Innovative Therapies for Children with Cancer (ITCC),
pubmed-author:FrappazDidierD,
pubmed-author:GentetJean-ClaudeJC,
pubmed-author:GeoergerBirgitB,
pubmed-author:HainSharonS,
pubmed-author:JaspanTimothyT,
pubmed-author:Le DeleyMarie-CecileMC,
pubmed-author:LeblondPierreP,
pubmed-author:Mc HughKieranK,
pubmed-author:VHH,
pubmed-author:VassalGillesG,
pubmed-author:ZwaanChristian MichelCM
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
230-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20943374-Adolescent,
pubmed-meshheading:20943374-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20943374-Child,
pubmed-meshheading:20943374-Child, Preschool,
pubmed-meshheading:20943374-Deoxycytidine,
pubmed-meshheading:20943374-Drug Administration Schedule,
pubmed-meshheading:20943374-Female,
pubmed-meshheading:20943374-Humans,
pubmed-meshheading:20943374-Infant,
pubmed-meshheading:20943374-Male,
pubmed-meshheading:20943374-Maximum Tolerated Dose,
pubmed-meshheading:20943374-Neoplasm Recurrence, Local,
pubmed-meshheading:20943374-Neoplasms,
pubmed-meshheading:20943374-Organoplatinum Compounds,
pubmed-meshheading:20943374-Treatment Outcome,
pubmed-meshheading:20943374-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.
|
|
pubmed:affiliation |
Institut Gustave Roussy, Université Paris-Sud, 39 rue Camille Desmoulins, 94805 Villejuif, France. geoerger@igr.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
